Michael S Hearne Odonate Therapeutics, Inc. (ODTC) insider trading activity
Michael S Hearne is Chief Financial Officer of Odonate Therapeutics, Inc.. Currently has a direct ownership of 2,620 shares of ODTC, which is worth approximately $393 Million. The most recent transaction as insider was on Mar 15, 2021, when has been sold 37 shares (Common Stock) at a price of $16.22 per share, resulting in proceeds of $600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
        Shares Held (Direct Ownership)
        2.62K
                  
          
      
      
    
                  
                    0%
                  
            3M change
          
                    
          
          
                
                  0%
                
             12M change
          
                    
        
        Total Value Held
          $393 Million
      
      
    Michael S Hearne Transaction History
Also insider at
        MSH
    
    
    Michael S Hearne
        Chief Financial Officer
      
       
        
        Waltham, MA